Skinuvita

Germany
Dankerath, Rheinland-Pfalz, Germany

Company profile

Skinuvita company profile

Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims to improve the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2021-09-01, Month

Headquarters

Country code
DE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$3.2M
Last funding
Seed / $2M / 2024-07-15
Last equity funding
Seed / $2M
Investors
8
Lead investors
2
Founders
5
Articles
1

Founders and investors

Founders

Jan B. ElsnerJanina ClasenJens PelzetterMaria Eugênia AraujoTill Fitzke

Lead investors

GCP-Service InvestHTGF (High-Tech Gruenderfonds)

Investors

Bremer Aufbau-Bank GmbHDie BrückenköpfeGIMIC VenturesHTGF (High-Tech Gruenderfonds)Meerkat Holding